Patents by Inventor Pascal Stuelsatz

Pascal Stuelsatz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230398104
    Abstract: Composition containing Nicotinamide and vitamin B6 are provided. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be administered to an individual in need thereof for treating muscle injury, and/or promoting muscle repair, improving skeletal muscle regeneration, maintaining or increasing skeletal muscle function and/or skeletal muscle mass in an individual with muscle injury.
    Type: Application
    Filed: October 29, 2021
    Publication date: December 14, 2023
    Inventors: PASCAL STUELSATZ, JEROME FEIGE, JORIS MICHAUD
  • Publication number: 20230390262
    Abstract: A composition contains Nicotinamide and pyridoxine. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be administered to an individual in need thereof orally or intravenously for preventing and/or treating sarcopenia, physical frailty, a loss of and/or improving skeletal muscle mass, lean muscle mass, skeletal muscle strength and/or skeletal muscle function.
    Type: Application
    Filed: October 29, 2021
    Publication date: December 7, 2023
    Inventors: PASCAL STUELSATZ, JEROME FEIGE, JORIS MICHAUD, EUGENIA LINDA MIGLIAVACCA
  • Publication number: 20230390264
    Abstract: A composition contains Nicotinamide and Vitamin B6, for example pyridoxine. The composition may be an oral nutritional composition, for example an infant formula, a follow up formula, a nutritional supplement, an oral nutritional supplement, a food product. The composition can be administered to an individual in need thereof for promoting muscle growth and/or for maintaining and/or increasing muscle function and/or muscle mass in infants and children. For example, the composition can be useful for increasing muscle function and/or muscle mass by modulating muscle stem cells.
    Type: Application
    Filed: October 29, 2021
    Publication date: December 7, 2023
    Inventors: PASCAL STUELSATZ, JEROME FEIGE, JORIS MICHAUD, SARA ANCEL
  • Publication number: 20230390263
    Abstract: Composition containing Nicotinamide and vitamin B6 are provided. The composition may be an oral nutritional composition, for example a nutritional supplement, an oral nutritional supplement, a food product, a food for special medical purpose (FSMP). The composition can be administered to an individual in need thereof for preventing and/or treating precachexia and/or cachexia, and/or promoting muscle repair, and/or improving skeletal muscle regeneration, and/or maintaining or increasing skeletal muscle function and/or skeletal muscle mass in an individual with cachexia or precachexia.
    Type: Application
    Filed: October 29, 2021
    Publication date: December 7, 2023
    Inventors: PASCAL STUELSATZ, JEROME FEIGE, JORIS MICHAUD
  • Publication number: 20220251470
    Abstract: A compound having the formula (1), (2), (3), or (4), or combinations thereof, for use to maintain or increase muscle function and/or mass in a subject, and/or prevent or reduce muscle wasting in a subject, wherein R1, R2? R3, R4, R5 and R6 are independently, a long chain fatty acid having between 16 and 20 carbons.
    Type: Application
    Filed: May 20, 2020
    Publication date: August 11, 2022
    Inventors: JEROME FEIGE, ELIZABETH FORBES-BLOM, JORIS MICHAUD, AMAURY PATIN, CLAIRE BOUTRY, PASCAL STUELSATZ
  • Publication number: 20220184025
    Abstract: The present invention relates to novel depside dimeric compounds for improving skeletal muscle plasticity regeneration to maintain or increase muscle function and/or muscle mass by modulating muscle stem cells. For example, the present invention is useful for subjects to promote muscle repair and/or subjects suffering from precachexia, cachexia, sarcopenia, myopathy, dystrophy and/or recovery after muscle injury or surgery.
    Type: Application
    Filed: March 24, 2020
    Publication date: June 16, 2022
    Inventors: Denis Marcel Barron, Benjamin Brinon, Jerome Feige, Sonia Karaz, Joris Michaud, Yann Ratinaud, Pascal Stuelsatz
  • Publication number: 20220175713
    Abstract: The present invention relates to novel depside trimeric compounds for improving skeletal muscle plasticity regeneration to maintain or increase muscle function and/or muscle mass by modulating muscle stem cells. For example, the present invention is useful for subjects to promote muscle repair and/or subjects suffering from precachexia, cachexia, sarcopenia, myopathy, dystrophy and/or recovery after muscle injury or surgery.
    Type: Application
    Filed: March 24, 2020
    Publication date: June 9, 2022
    Inventors: Denis Marcel Barron, Benjamin Brinon, Jerome Feige, Sonia Karaz, Joris Michaud, Yann Ratinaud, Pascal Stuelsatz
  • Publication number: 20220054448
    Abstract: The present invention relates to novel polymethoxyflavone compounds for improving skeletal muscle plasticity regeneration to maintain or increase muscle function and/or muscle mass by modulating muscle stem cells. For example, the present invention is useful for subjects to promote muscle repair and/or subjects suffering from precachexia, cachexia, sarcopenia, myopathy, dystrophy and/or recovery after muscle injury or surgery.
    Type: Application
    Filed: December 17, 2019
    Publication date: February 24, 2022
    Inventors: Joris Michaud, Jerome Feige, Pascal Stuelsatz, Sonia Karaz, Denis Marcel Barron, Yann Ratinaud, Benjamin Brinon
  • Publication number: 20220047552
    Abstract: The present invention relates to novel Raf-1 kinase inhibitor compounds for improving skeletal muscle regeneration to maintain or increase muscle function and/or muscle mass by modulating muscle stem cells. For example, the present invention is useful for subjects to promote muscle repair and/or subjects suffering from precachexia, cachexia, sarcopenia, myopathy, dystrophy and/or recovery after muscle injury or surgery.
    Type: Application
    Filed: September 12, 2019
    Publication date: February 17, 2022
    Inventors: Denis Marcel Barron, Jerome Feige, Sonia Karaz, Joris Michaud, Yann Ratinaud, Pascal Stuelsatz